It has been known for 50 years that transaminase activity increases in patients with acute
myocardial infarction. With the development of creatine kinase (CK), biomarkers of cardiac …

The use of biomarkers to aid diagnosis and treatment is increasing rapidly as genomics and
proteomics help us expand the number of markers we can use and as an improved …

Background—This study determined the prevalence of increased cardiac troponin I (cTnI)
and T (cTnT) in end-stage renal disease (ESRD) patients and whether an increased …

ContextCardiac troponin T (cTnT) and C-reactive protein (CRP) are prognostic markers in
acute coronary syndromes. However, for patients with end-stage renal disease (ESRD) the …

Background—Earlier, rapid evaluation in chest pain units may make patient care more
efficient. A multimarker strategy (MMS) testing for several markers of myocardial necrosis …

Background: In patients with end-stage renal disease (ESRD), the ability of single and
multiple biomarker monitoring to predict adverse outcomes has not been well established …

Background: Although the prognostic importance of troponin in patients with anacute
coronary syndrome is clear, the significance of troponin elevation after elective …

BACKGROUND: Because of possible adverse outcomes, many of the> 6 million annual
emergency department (ED) patients with suspected acute coronary syndromes (ACS) …

Background—Troponin T (TnT) is valuable for short-and long-term risk stratification of
patients with acute coronary syndromes (ACS). It also may predict which ACS patients will …

Background—Cardiac troponin T (cTnT) and I elevations are associated with a higher risk of
adverse events, a higher incidence of multivessel disease, complex lesions, and visible …